The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Bradwejn, J.
* Articles by Bourin, M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Bradwejn, J.
* Articles by Bourin, M.
Am J Psychiatry 155:280-282, February 1998
© 1998 American Psychiatric Association


Brief Report

Effects of Cholecystokinin Tetrapeptide on Respiratory Function in Healthy Volunteers

Jacques Bradwejn, M.D., F.R.C.P.C., Jean-Marc LeGrand, M.D., Diana Koszycki, Ph.D., Jason H.T. Bates, Ph.D., and Michel Bourin, M.D.

OBJECTIVE: The authors evaluated respiratory response to cholecystokinin tetrapeptide (CCK-4) in healthy volunteers. METHOD: Subjects were randomly assigned to either a CCK-4 (N=15) or placebo (N=15) challenge under double-blind conditions. RESULTS: Dyspnea was reported by all of the subjects who received CCK-4 but only one subject who received placebo. CCK-4 caused a significant increase in tidal volume and minute ventilation but had no effect on breathing frequency. Placebo had no effect on any of the respiratory measures. CONCLUSIONS: These data indicate that the behavioral effects of CCK-4 are accompanied by changes in respiration in healthy volunteers. (Am J Psychiatry 1998; 155:280–282)




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
C. Gilles and R. Luthringer
Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs
J Psychopharmacol, May 1, 2007; 21(3): 272 - 282.
[Abstract] [PDF]


Home page
Psychosom. Med.Home page
D. Koszycki, S. Torres, J. E. Swain, and J. Bradwejn
Central Cholecystokinin Activity in Irritable Bowel Syndrome, Panic Disorder, and Healthy Controls
Psychosom Med, July 1, 2005; 67(4): 590 - 595.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. Saaresranta and O. Polo
Hormones and Breathing
Chest, December 1, 2002; 122(6): 2165 - 2182.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
F. Noble, S. A. Wank, J. N. Crawley, J. Bradwejn, K. B. Seroogy, M. Hamon, and B. P. Roques
International Union of Pharmacology. XXI. Structure, Distribution, and Functions of Cholecystokinin Receptors
Pharmacol. Rev., December 1, 1999; 51(4): 745 - 781.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org